Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MYLES, A. B.
Right arrow Articles by RIDLEY, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MYLES, A. B.
Right arrow Articles by RIDLEY, M. G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1992 British Society for Rheumatology

other

PREVENTION OF BLINDNESS IN GIANT CELL ARTERITIS BY CORTICOSTEROID TREATMENT

A. B. MYLES, T. PERERA and M. G. RIDLEY

Department of Rheumatology, St Peter's Hospital Chertsey, Surrey KT160PZ

Correspondence to: Correspondence to Dr A. Myles

Ninety-six patients with giant cell arteritis (GCA) seen from 1968 to 1985 were studied with regard to the starting dose of prednisolone and the development of serious ocular complications, which proved to be very few after treatment was started. Those starting on 20 mg of prednisolone or less daily fared at least as well as those starting on higher doses. Analysis of the literature does not support the belief that higher doses provide greater protection from blindness.

KEY WORDS: Glucocorticoid therapy, Temporal artery biopsy, Amaurosis fugax, Polymyalgia rheumatica


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Neurol. Neurosurg. PsychiatryHome page
T. Loddenkemper, P. Sharma, I Katzan, and G. T Plant
Risk factors for early visual deterioration in temporal arteritis
J. Neurol. Neurosurg. Psychiatry, November 1, 2007; 78(11): 1255 - 1259.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
U. B.S. Prakash
Uncommon Causes of Cough: ACCP Evidence-Based Clinical Practice Guidelines
Chest, January 1, 2006; 129(1_suppl): 206S - 219S.
[Abstract] [Full Text] [PDF]

Home page
 Br J OphthalmolHome page
M. J Kupersmith, R. Langer, H. Mitnick, R. Spiera, H. Spiera, M. Richmond, and S. Paget
Visual performance in giant cell arteritis (temporal arteritis) after 1 year of therapy
Br J Ophthalmol, July 1, 1999; 83(7): 796 - 801.
[Abstract] [Full Text]

Home page
 BMJHome page
A B Myles
Polymyalgia rheumatica and giant cell arteritis
BMJ, November 4, 1995; 311(7014): 1232 - 1232.
[Full Text]

Home page
 Arch Fam MedHome page
D. A. Weinberg, P. J. Savino, R. C. Sergott, and T. M. Bosley
Giant Cell Arteritis: Corticosteroids, Temporal Artery Biopsy, and Blindness
Arch Fam Med, July 1, 1994; 3(7): 623 - 627.
[Abstract] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.